Pharming reports Q3 revenue above expectations and tightens 2026 guidance
FROM THE WIRE · SEEKINGALPHA.COM
* Pharming press release [https://seekingalpha.com/pr/20695614-pharming-group-announces-third-quarter-2026-revenues-above-market-expectations] (PHAR [https://seekingalpha.com/symbol/PHAR]): Q3 Revenue of $117.6M (+20.9% Y/Y). * Full-year 2026 outlookTightened 2026 total revenue…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishStrong quarterly revenue and a tighter guidance range raise the floor for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q3 revenue was $117.6 million, up 20.9% year over year.
- 022026 revenue guidance was tightened to $380-390 million.
- 03Total operating expense guidance was lowered to $310-315 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets